Cost‐effectiveness of maribavir versus conventional antiviral therapies for post‐transplant refractory cytomegalovirus infection with or without genotypic resistance: A US perspective
B. G. Schultz, C. Kotton, G. Jutlla, R. Ressa +7 more
2024Journal of Medical Virology11 citations Open access
Semantic Scholar

